comparemela.com

Latest Breaking News On - Abha damani - Page 1 : comparemela.com

Access to finance, investments in health, saving schemes and more–what women entrepreneurs expect from Budget

Access to finance, investments in health, saving schemes and more–what women entrepreneurs expect from Budget
yourstory.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yourstory.com Daily Mail and Mail on Sunday newspapers.

ICPA Health launches handheld oral healthcare device

ICPA Health launches handheld oral healthcare device
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

ICPA aims to capture geriatric market

ICPA suggests govt to include chlorhexidine mouthwash for COVID‐19 prevention

ICPA suggests govt to include chlorhexidine mouthwash for COVID‐19 prevention ICPA suggests govt to include chlorhexidine mouthwash for COVID‐19 prevention 12 May 2021 | News Lancet s study in April 2020 showed that Chlorhexidine in a concentration as low as 0.05 percent could inactivate SARS-COV-2. Image credit- shutterstock.com ICPA Health Products Ltd (ICPA), Mumbai based pharmaceutical company, has submitted a representation to the Government requesting the inclusion of Chlorhexidine mouthwash to the list of precautionary measures and best health practices to reduce COVID19 transmission effectively. In the representation, ICPA has cited multiple independent studies that indicated that rinsing the mouth and gargling the throat with Chlorhexidine mouthwash eliminates the virus and reduces its transmission.

ICPA Health launches antibiotic to treat odontogenic infections

ICPA Health launches antibiotic to treat odontogenic infections ICPA Health launches antibiotic to treat odontogenic infections 02 March 2021 | News ICPAMOX – CV 625 is recommended for use along with dental treatments like root canal, tooth extractions and various oral surgeries to reduce post-operative infection. Mumbai based ICPA Health Products Ltd (ICPA), a leading pharmaceutical company and pioneers in the oral-health segment, has launched ICPAMOX – CV 625 meant to treat odontogenic infections. The product is an antibiotic with a broad-spectrum activity against the commonly occurring bacterial pathogens in the oral cavity and other parts of the body. An antibiotic indicated in multiple conditions, ICPAMOX – CV 625 is recommended for use along with dental treatments like root canal, tooth extractions and various oral surgeries to reduce post-operative infection.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.